EuropaBio urges EU Parliament to increase 2007 EMEA budget
EuropaBio urged the EU Parliament to increase the European Medicines Agency's (EMEA's) 2007 budget. The vote takes place in the European Parliament on 26 October 2006.
"It is vital for Europe's life sciences based progress in healthcare that the EMEA's funds are increased for 2007. This will mean it can continue its key role as a rigorous scientific and independent expert review body that promotes healthcare for the benefit of patients," stated Dr. Andrea Rappagliosi, Chairman of EuropaBio's Healthcare Council. "The EMEA must be adequately funded to ensure that patients across Europe benefit from equal access to European biotech innovation in a timely manner."
Representatives from the Biotech industry's national associations met with over 50 of their representatives in Brussels recently to urge support for the EMEA's 2007 budget so that the Agency can:
- Adequately support sponsors of orphan medicinal products for rare diseases,
- Implement the new provisions for Small & Medium-sized Enterprises,
- Ensure the highest level of scientific advice and guidance in clinical development especially in the field of genetics and pharmacogenetics, as well as new advanced therapies,
- Fulfill new tasks resulting from the upcoming Regulation on medicinal products for paediatric use.
Other news from the department politics & laws
